Casey Orvin Chief Commercial Officer
CenExel
Casey is Chief Commercial Officer for CenExel, the U.S. leader of independent wholly-owned clinical research sites, representing 19 Centers of Excellence specializing in inpatient and outpatient services in a wide range of therapeutic areas including Psychiatry, CNS, Analgesics/Pain, Dermatology and Vaccines.
Casey has a long and exemplary career history in pharmaceutical research services and began his career leading a large pharmaceutical research site network, Research Solutions. He was then recruited to join Clinical Research Advantage/Radiant as EVP of BD and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under Casey’s leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. He facilitated the acquisition of two competitors securing the company’s spot as what was at the time the largest clinical research site network in the US. In 2015, Casey and the executive team at Radiant merged with Synexus, a division of PPD. With Casey’s guidance, Synexus continued to expand to 215 global clinical sites in 4 continents and over 15 countries. Casey also served as President of the Society for Clinical Research Sites from 2019-2021.
Casey is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one. As a thought leader in the industry, Casey is regularly invited to be a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, he was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.